Loncastuximab Tesirine
ADCT-402-105
Phase 1 small_molecule active
Quick answer
Loncastuximab Tesirine for B-Cell Non-Hodgkin Lymphoma is a Phase 1 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- B-Cell Non-Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active